Literature DB >> 26642336

HLA-identical siblings versus haploidentical donors: full match still beats half match.

R Hanna1,2, N S Majhail1,3.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26642336     DOI： 10.1038/bmt.2015.291

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  12 in total

1.  Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts.

Authors:  Claudio G Brunstein; Ephraim J Fuchs; Shelly L Carter; Chatchada Karanes; Luciano J Costa; Juan Wu; Steven M Devine; John R Wingard; Omar S Aljitawi; Corey S Cutler; Madan H Jagasia; Karen K Ballen; Mary Eapen; Paul V O'Donnell
Journal:  Blood       Date:  2011-04-28       Impact factor: 22.113

2.  Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide.

Authors:  Shannon R McCurdy; Jennifer A Kanakry; Margaret M Showel; Hua-Ling Tsai; Javier Bolaños-Meade; Gary L Rosner; Christopher G Kanakry; Karlo Perica; Heather J Symons; Robert A Brodsky; Douglas E Gladstone; Carol Ann Huff; Keith W Pratz; Gabrielle T Prince; Amy E Dezern; Ivana Gojo; William H Matsui; Ivan Borrello; Michael A McDevitt; Lode J Swinnen; B Douglas Smith; Mark J Levis; Richard F Ambinder; Leo Luznik; Richard J Jones; Ephraim J Fuchs; Yvette L Kasamon
Journal:  Blood       Date:  2015-03-26       Impact factor: 22.113

Review 3.  HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide.

Authors:  E J Fuchs
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

4.  Causes of mortality after haploidentical hematopoietic stem cell transplantation and the comparison with HLA-identical sibling hematopoietic stem cell transplantation.

Authors:  C H Yan; L P Xu; F R Wang; H Chen; W Han; Yu Wang; J Z Wang; K Y Liu; X J Huang
Journal:  Bone Marrow Transplant       Date:  2015-12-21       Impact factor: 5.483

5.  Comparison of Outcomes of Hematopoietic Cell Transplants from T-Replete Haploidentical Donors Using Post-Transplantation Cyclophosphamide with 10 of 10 HLA-A, -B, -C, -DRB1, and -DQB1 Allele-Matched Unrelated Donors and HLA-Identical Sibling Donors: A Multivariable Analysis Including Disease Risk Index.

Authors:  Asad Bashey; Xu Zhang; Katelin Jackson; Stacey Brown; Michelle Ridgeway; Melhem Solh; Lawrence E Morris; H Kent Holland; Scott R Solomon
Journal:  Biol Blood Marrow Transplant       Date:  2015-09-07       Impact factor: 5.742

Review 6.  Immune reconstitution after haploidentical hematopoietic stem cell transplantation.

Authors:  Ying-Jun Chang; Xiao-Yu Zhao; Xiao-Jun Huang
Journal:  Biol Blood Marrow Transplant       Date:  2013-12-04       Impact factor: 5.742

7.  Immune reconstitution following unmanipulated HLA-mismatched/haploidentical transplantation compared with HLA-identical sibling transplantation.

Authors:  Ying-Jun Chang; Xiang-Yu Zhao; Ming-Rui Huo; Lan-Ping Xu; Dai-Hong Liu; Kai-Yan Liu; Xiao-Jun Huang
Journal:  J Clin Immunol       Date:  2011-12-16       Impact factor: 8.317

8.  "Designed" grafts for HLA-haploidentical stem cell transplantation.

Authors:  Massimo F Martelli; Mauro Di Ianni; Loredana Ruggeri; Antonio Pierini; Franca Falzetti; Alessandra Carotti; Adelmo Terenzi; Yair Reisner; Franco Aversa; Brunangelo Falini; Andrea Velardi
Journal:  Blood       Date:  2013-12-20       Impact factor: 22.113

9.  Incidence of invasive fungal disease after unmanipulated haploidentical stem cell transplantation was significantly higher than that after HLA-matched sibling transplantation.

Authors:  Y Sun; L Xu; D Liu; X Zhang; W Han; Y Wang; H Chen; Y Chen; F Wang; J Wang; Y Ji; F Tang; K Liu; X-J Huang
Journal:  Clin Microbiol Infect       Date:  2013-04-08       Impact factor: 8.067

10.  Haploidentical T Cell-Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen-Matched Related or Unrelated Donor.

Authors:  Didier Blaise; Sabine Fürst; Roberto Crocchiolo; Jean El-Cheikh; Angela Granata; Samia Harbi; Reda Bouabdallah; Raynier Devillier; Stephania Bramanti; Claude Lemarie; Christophe Picard; Christian Chabannon; Pierre-Jean Weiller; Catherine Faucher; Bilal Mohty; Norbert Vey; Luca Castagna
Journal:  Biol Blood Marrow Transplant       Date:  2015-09-01       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.